title: Sensorineural hearing loss following imatinib (Gleevec) administration.
authors.affiliation: Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.
authors.forename: Harrison W
authors.initials: HW
authors.lastname: Lin
authors.forename: Daniel S
authors.initials: DS
authors.lastname: Roberts
authors.forename: Jonathan
authors.initials: J
authors.lastname: Kay
authors.forename: Konstantina M
authors.initials: KM
authors.lastname: Stankovic
mesh_terms: D001549:Benzamides / Q000009:adverse effects*; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate